United States Infectious Vaccines Market was valued at USD 12 Billion in 2022 and is projected to reach USD 22 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030.
The US Infectious Vaccines Market is experiencing a significant evolution as the demand for vaccines continues to rise, driven by advancements in technology, growing awareness about infectious diseases, and the increasing need for preventative healthcare solutions. This dynamic market caters to a wide range of industries, with several factors influencing vaccine requirements across various sectors.
One of the key drivers in the Infectious Vaccines Market is the pharmaceutical industry's push for innovative vaccine solutions. The rapid development of new vaccines, particularly in response to pandemics such as COVID-19, has accelerated the industry's growth. Biotechnology companies are investing heavily in research to create vaccines that target a broader spectrum of infectious diseases, including respiratory infections, HIV, and malaria. As a result, the market is expected to continue expanding in the coming years.
Industries such as healthcare, agriculture, and travel are among the primary consumers of vaccines. In healthcare, the growing emphasis on immunization to prevent outbreaks has led to a surge in vaccine demand. Hospitals, clinics, and healthcare providers are increasingly seeking reliable vaccine suppliers to ensure their populations are protected from preventable diseases. Additionally, the agriculture industry relies on vaccines to safeguard livestock, preventing the spread of diseases like avian influenza and foot-and-mouth disease. Travel industries also play a role, as international travelers require specific vaccinations before embarking on trips to certain regions.
The Infectious Vaccines Market also sees demand from government agencies and organizations focused on public health. With increasing concerns about global health security, governments are investing in large-scale vaccination programs, particularly for diseases that have pandemic potential. These public health initiatives are critical in controlling infectious outbreaks and maintaining overall societal health.
Looking ahead, the Infectious Vaccines Market will likely witness continued growth, driven by ongoing advancements in vaccine development, changing regulatory requirements, and expanding global demand. Industries involved in healthcare, agriculture, and public health will remain central to the market, ensuring that vaccines are accessible and effective in preventing the spread of infectious diseases.
Get an In-Depth Research Analysis of the US Infectious Vaccines Market Size And Forecast [2025-2032]
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc (U.S.)
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Infectious Vaccines Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Infectious Vaccines Market
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Subunit Vaccines
mRNA Vaccines
DNA Vaccines
Viral Infections
Bacterial Infections
Parasitic Infections
Injectable Vaccines
Oral Vaccines
Intranasal Vaccines
Healthcare Providers
Pharmaceutical Companies
Government and NGOs
Research Institutions
Pediatric Vaccines
Adult Vaccines
Geriatric Vaccines
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Infectious Vaccines Market Research Analysis
1. Introduction of the US Infectious Vaccines Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Infectious Vaccines Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Infectious Vaccines Market, By Type
6. US Infectious Vaccines Market, By Application
7. US Infectious Vaccines Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Infectious Vaccines Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/